US-China Biomedical Technology (US-China Biomedical Technology) Beta : -0.28 (As of Jun. 21, 2024)

US-China Biomedical Technology Beta Chart

US-China Biomedical Technology Quarterly Data
	Aug14	Nov14	Feb15	May15	Aug15	Nov15	Feb16	May16	Aug16	Nov16	Feb17	May17	Aug17	Nov17	Feb18	May18	Aug18	Nov18	Feb19	May19
Beta	Get a 7-Day Free Trial															-4.04	-4.08	-2.25	-0.35	0.35

Competitive Comparison of US-China Biomedical Technology's Beta

For the Health Information Services subindustry, US-China Biomedical Technology's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

US-China Biomedical Technology's Beta Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, US-China Biomedical Technology's Beta distribution charts can be found below:

* The bar in red indicates where US-China Biomedical Technology's Beta falls into.

US-China Biomedical Technology Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

US-China Biomedical Technology  (GREY:UCBB) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)

US-China Biomedical Technology Beta Related Terms

Thank you for viewing the detailed overview of US-China Biomedical Technology's Beta provided by GuruFocus.com. Please click on the following links to see related term pages.

US-China Biomedical Technology (US-China Biomedical Technology) Business Description